A recent narrative review suggests that traditional metrics like the Apnoea-Hypopnoea Index (AHI) are insufficient for ...

Nearly 800 respiratory specialists and healthcare professionals gathered in Ho Chi Minh City for a congress focused on ...

This growth is driven by the increasing prevalence of respiratory diseases, rising number of surgical and critical care ...

Magnesium rarely gets the spotlight, but it has widely become known that it supports more than 300 enzyme reactions in the ...

India today launched world’s first-ever, landmark clinical study that will, for the first time globally, scientifically ...

Comprehensive, up-front full-panel NGS across lung cancer stages is preferred to conserve tissue and avoid sequential testing ...

This week Dr Ray O’Connor takes a look at the potential role of medication and vaccination on the prevention of dementia and ...

Current Landscape of Life Sciences The life sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices ...

Biotech innovator Liquidia, focused on therapies for rare conditions, reported a notable insider sale amid strong recent share performance.

This biotech innovator in immunology reported a notable insider sale as its stock outperformed and drug development efforts ...

This biotech innovator in rare disease therapies reported significant insider selling amid a year of robust stock performance ...

Yutrepia's initial commercialization impresses, but mounting competitive threats cloud long-term prospects for Liquidia. See ...